CCI study looks at risks for patients with diabetes treated with PCI

09/23/2013 | Healio

Diabetes patients who underwent PCI for STEMI had nearly four times the mortality rate of patients who did not have diabetes, according to results from the INFUSE-AMI trial published in Catheterization and Cardiovascular Interventions. Study participants with diabetes had more extensive left anterior descending artery disease, more comorbidities and a 30-day mortality rate of 8.1%, compared with 2.3% among the group without diabetes. The 30-day revascularization rate was 6.4% for diabetes patients compared with 1% for non-diabetes patients.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Health Plan Administration, Payor Relations and Contracting
St. Charles Health System
Bend, OR
Compliance Sr Mgr
Amgen
Thousand Oaks, CA
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA